Search for your doctor or find doctors accepting new patients.
Find out about our hospital visiting hours and policies.
Log In to MyUCSDChart to access your medical information
Find out about our academic nursing program.
On Monday, April 9, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System implanted the new FDA-approved LINX device in a 29-year old patient suffering from gastroesophageal reflux disease (GERD), a chronic digestive disease that can lead to severe inflammation, stricture, Barrett’s esophagus and esophageal cancer.
The LINX system is composed of a series of titanium beads, each with a magnetic core, that are connected to form a ring shape. It is implanted at the lower esophageal sphincter (LES), a circular band of muscle that closes the last few centimeters of the esophagus and prevents the backward flow of stomach contents.
The FDA approved the LINX Reflux Management System in March 2012. Horgan and his surgical team have implanted more than 20 of the devices during the clinical trial phase, representing the most surgeries in the second phase of procedures that led to FDA approval.
The LINX device is an option for patients who do not respond to dietary and lifestyle measures. The device can be placed during a 20-30 minute minimally invasive surgery. Patients may leave the hospital the same day after brief observation.
Click on the above image to watch video of Horgan discussing LINX technique for GERD.
The LINX Reflux Management System is manufactured by Torax Medical Inc. in St. Paul, Minn.
To learn more about eligibility for the LINX device at UC San Diego Health System, please call 619-471-0447.
# # #
Media Contact: Jackie Carr, 619-543-6163, firstname.lastname@example.org
Official Web Site of the University of California, San Diego.